IDEAYA Biosciences (IDYA) Tops Q3 EPS by 133c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q3 EPS of $1.33. Revenue for the quarter came in at $207.83 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Clariant AG (CLN:SW) (CLZNY) PT Raised to CHF13 at JPMorgan
• Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold